Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK)

Price 1,553.00p on 26-07-2024 at 17:55:57
Change 29.50p 1.94%
Buy 1,555.50p
Sell 1,555.00p
Buy / Sell GSK Shares
Last Trade: Unknown 100,321.00 at 1,669.26p
Day's Volume: 5,189,560
Last Close: 1,553.00p
Open: 1,525.00p
ISIN: GB00BN7SWP63
Day's Range 1,521.50p - 1,557.50p
52wk Range: 1,330.20p - 1,820.00p
Market Capitalisation: £63,334m
VWAP: 1,549.81085p
Shares in Issue: 4,078m

Recent Trades History Glaxosmithkline (GSK)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 100,321 1,669.26p OTC Trade
17:55:55 - 26-Jul-24
Buy* 8 1,553.00p SI Trade
Negotiated Trade
15:49:11 - 26-Jul-24
Buy* 2,580 1,553.00p Automatic Execution
15:39:54 - 26-Jul-24
Buy* 5,160 1,553.00p Automatic Execution
15:39:13 - 26-Jul-24
Buy* 7,740 1,553.00p Automatic Execution
15:39:12 - 26-Jul-24
Buy* 2,580 1,553.00p Automatic Execution
15:39:10 - 26-Jul-24
Buy* 2,580 1,553.00p Automatic Execution
15:39:06 - 26-Jul-24
Buy* 2,580 1,553.00p Automatic Execution
15:39:06 - 26-Jul-24
Buy* 2,580 1,553.00p Automatic Execution
15:37:52 - 26-Jul-24
Buy* 5,160 1,553.00p Automatic Execution
15:37:33 - 26-Jul-24

Share Price History for Glaxosmithkline

Time period:
to
Date Open High Low Close Volume

Share News for Glaxosmithkline

UK earnings, trading statements calendar - next 7 days

24th Jul 2024 14:45

Read More

GSK announces promising trial data for ViiV Healthcare HIV drugs

23rd Jul 2024 12:07

(Alliance News) - GSK PLC on Tuesday reported "positive" data for testing on three different treatments by ViiV Healthcare, its majority-owned specialist HIV company. Read More

LONDON MARKET OPEN: Stocks suffer on underwhelming local data

19th Jul 2024 08:57

(Alliance News) - The FTSE 100 opened higher in London on Friday morning, while other stocks remained downbeat, as a nationwide tech outage combined with gloomy retail sales data at the start of the day. Read More

GSK drug for multiple myeloma accepted for European regulatory review

19th Jul 2024 08:12

(Alliance News) - GSK PLC on Friday said its treatment for relapsed or refractory multiple myeloma has been accepted for review by a European regulatory panel. Read More

GSK moves to new global headquarters in return to central London

14th Jul 2024 11:18

(Alliance News) - Pharmaceutical company GSK PLC is set to move its global headquarters back to central London, ending more than two decades at its Brentford base. Read More

FTSE 100 Latest
Value8,285.71
Change99.36

Login to your account

Forgot Password?

Not Registered